← Back to Clinical Trials
Recruiting NCT05814237

POS-ARI-ER Observational Study of Acute Respiratory Infections

Trial Parameters

Condition Acute Respiratory Infection
Sponsor European Clinical Research Alliance for Infectious Diseases (ECRAID)
Study Type OBSERVATIONAL
Phase N/A
Enrollment 11,750
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-06-20
Completion 2026-02-28
Interventions
Data collection

Brief Summary

Acute respiratory infections (ARI) are one of the most frequent reasons for hospital admission and antibiotic use, and can be caused by a broad range of pathogens, including respiratory viruses with proven epidemic potential, e.g. influenza and coronaviruses. The POS-ARI-ER study will focus on describing the different routine diagnostic and therapeutic practices in the work-up and treatment of ARI, as well as clinical outcomes across the patient population. In addition, POS-ARI-ER aims to characterise both the adult patient population with ARI presenting to acute hospital settings in Europe, and the aetiology of ARI in these patients.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years * Clinical suspicion of a new episode of acute respiratory tract infection, with onset in the last 10 days * Patient presents to an emergency room or secondary care setting * Informed consent is provided by patient or their legal representative Exclusion Criteria: * Patient has been transferred from another hospital * Patient admitted to hospital for \>2 days at the time of enrolment * Patient has been previously enrolled in the POS-ARI-ER study

Related Trials